Cargando…
Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid
AIMS: To describe naloxone dispensing in Medicaid fee-for-service (FFS) and examine relationships between copays and coverage limits for naloxone and its dispensing rates. METHODS: Cross-sectional study using Medicaid FFS State Drug Utilization Data to quantify the use of naloxone in 2018. The prima...
Autores principales: | Messinger, John C, Kesselheim, Aaron S, Vine, Seanna M, Fischer, Michael A, Barenie, Rachel E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528040/ https://www.ncbi.nlm.nih.gov/pubmed/36199698 http://dx.doi.org/10.1177/11782218221126972 |
Ejemplares similares
-
Medicaid prescription limits and their implications for naloxone accessibility
por: Roberts, Andrew W., et al.
Publicado: (2021) -
Effect of electronic prescribing with formulary decision support on medication tier, copayments, and adherence
por: Pevnick, Joshua M, et al.
Publicado: (2014) -
Canadian national consensus guidelines for naloxone prescribing by pharmacists
por: Tsuyuki, Ross T., et al.
Publicado: (2020) -
Letter to the Editor regarding: Medicaid prescription limits and their implications for naloxone accessibility (by Roberts et al., 2021)
por: Talbert, Jeffery, et al.
Publicado: (2021) -
Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension
por: Schikowski, Erin M., et al.
Publicado: (2022)